D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -16.64% -141.76% 23.37% -62.60% -119.71%
Total Depreciation and Amortization -2.01% -1.18% -3.78% -2.34% -4.32%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 103.86% -50.26% -1.10% -16.78% -44.64%
Change in Net Operating Assets -73.94% 88.06% -176.78% 113.27% 470.33%
Cash from Operations -149.15% 47.92% -168.25% 28.27% 1,147.32%
Capital Expenditure 71.43% 65.58% 89.66% 80.11% 76.43%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 79.86% 231.43% -230.71% -157.24% -180.30%
Cash from Investing 79.80% 229.93% -233.17% -158.50% -183.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -96.54% -56.66% 519.54% -- 5,561.25%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -96.54% -56.66% 519.54% -102.78% 5,561.25%
Foreign Exchange rate Adjustments 472.73% -242.62% 256.25% -92.86% -134.38%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -119.84% 152.40% -411.81% -321.91% 140.70%